NCT07114094 Development, Validation and Evaluation of a Deprescribing Tool
| NCT ID | NCT07114094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indian Council of Medical Research |
| Condition | Elderly |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,650 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,650 participants in total. It began in 2025-05-01 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if a deprescribing tool can help in reducing prescriptions with potentially inappropriate medications (PIMs), in the Indian elderly population. The main question it aims to answer is- Can inappropriate polypharmacy in elderly patients be reduced through development and implementation of a deprescribing tool relevant to the Indian context? Researchers will compare control arm outcome parameters to see if there is a reduction in Proportion of prescriptions with at least one PIM ( Primary outcome parameter). Participating Prescribers ( Physicians) will be randomized to Control or Intervention arms. Particpating patients will not be randomized, and will receive routine consultation with a Physician who does not use the Deprescribing Tool (Control arm) or a prescriber who uses the Deprescribing tool ( Intervention Arm)
Eligibility Criteria
Inclusion Criteria: * Elderly patients (≥ 60 years) of either sex, visiting the General Medicine/ Community and Family Medicine OPD of the study sites Exclusion Criteria: * Patients not willing to participate in the study
Contact & Investigator
Dr. Jerin J Cherian, MD
STUDY CHAIR
Indian Council of Medical Research and Karolinska Institute, Sweden
Frequently Asked Questions
Who can join the NCT07114094 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07114094 currently recruiting?
Yes, NCT07114094 is actively recruiting participants. Contact the research team at rati.pharm@aiimsbhopal.edu.in for enrollment information.
Where is the NCT07114094 trial being conducted?
This trial is being conducted at Bangalore, India, Bhopal, India.
Who is sponsoring the NCT07114094 clinical trial?
NCT07114094 is sponsored by Indian Council of Medical Research. The principal investigator is Dr. Jerin J Cherian, MD at Indian Council of Medical Research and Karolinska Institute, Sweden. The trial plans to enroll 1,650 participants.